$243 Million is the total value of Pivotal bioVenture Partners Investment Advisor LLC's 11 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 10.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
KRTX | Buy | KARUNA THERAPEUTICS INC | $142,043,933 | -5.6% | 782,008 | +2.1% | 58.49% | -10.6% |
PCVX | VAXCYTE INC | $25,975,102 | -21.8% | 693,039 | 0.0% | 10.70% | -26.0% | |
INZY | Buy | INOZYME PHARMA INC | $18,413,848 | +559.0% | 3,213,586 | +20.8% | 7.58% | +524.0% |
New | OCULIS HOLDING AGordinary shares | $17,692,286 | – | 2,381,196 | +100.0% | 7.28% | – | |
RALLYBIO CORP | $13,730,517 | -13.1% | 2,404,644 | 0.0% | 5.65% | -17.7% | ||
ARQT | ARCUTIS BIOTHERAPEUTICS INC | $6,259,451 | -25.7% | 569,041 | 0.0% | 2.58% | -29.6% | |
FUSN | Sell | FUSION PHARMACEUTICALS INC | $5,884,902 | +19.7% | 1,560,982 | -0.0% | 2.42% | +13.3% |
VIGIL NEUROSCIENCE INC | $5,488,225 | -21.7% | 560,595 | 0.0% | 2.26% | -25.8% | ||
EXSCIENTIA PLCads | $4,093,111 | -0.6% | 772,285 | 0.0% | 1.68% | -5.9% | ||
BOLT | BOLT BIOTHERAPEUTICS INC | $2,629,139 | +6.9% | 1,891,467 | 0.0% | 1.08% | +1.3% | |
ALGS | ALIGOS THERAPEUTICS INC | $649,570 | -8.3% | 743,215 | 0.0% | 0.27% | -13.3% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
KARUNA THERAPEUTICS INC | 12 | Q3 2023 | 65.4% |
VAXCYTE INC | 12 | Q3 2023 | 19.5% |
INOZYME PHARMA INC | 12 | Q3 2023 | 10.8% |
ARCUTIS BIOTHERAPEUTICS INC | 12 | Q3 2023 | 6.2% |
FUSION PHARMACEUTICALS INC | 12 | Q3 2023 | 6.2% |
ALIGOS THERAPEUTICS INC | 12 | Q3 2023 | 8.0% |
BOLT BIOTHERAPEUTICS INC | 11 | Q3 2023 | 20.0% |
RALLYBIO CORP | 9 | Q3 2023 | 14.1% |
AKOUOS INC | 8 | Q3 2022 | 11.7% |
EXSCIENTIA PLC | 8 | Q3 2023 | 6.4% |
View Pivotal bioVenture Partners Investment Advisor LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Pivotal bioVenture Partners Investment Advisor LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.